Disc Medicine, Inc, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,...
UPM Biomedicals, the forerunner in producing high quality nanofibrillar cellulose for medical and life science applications, announces the launch of FibGel™— a natural injectable hydrogel...
AbbVie and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric...
Alphina Therapeutics, a biotechnology company developing a best-in-class NAMPT inhibitor for the treatment of a range of solid tumor indications, announced that it has...
Integral Molecular, a leader in developing advanced technologies for the discovery of vaccines and therapeutics, is excited to announce a five-year, $8 million contract from...
